As part of their RAMP experience, Scholars may have the opportunity to contribute to scholarly presentations and manuscripts as lead or contributing authors. Below are publications resulting from RAMP Scholar projects.
Behrens S, LaBranche CC, Zhou T, Wiehe K, Bonsignori M, Sattentau QJ, Eaton A, Greene K, Gao H, Williams WB, Saunders K, Perez LG, Korber BT, Kwong PD, Mascola JR, McGuire AT, Stamatatos L, Acharya P, Haynes BF, Montefiori DC. Germline-Targeting and Reverse Engineering to Elicit CH235.12 Lineage BNAbs. Poster Presentation, HIVR4P, Madrid, Spain, October 21-25, 2018.
Thiam-Diouf A, Metch B, Sharpe C, Mulugeta R, Andrasik MP. Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention. Vaccine. 2018 Feb 21;36(9):1235-1242.
Musuruana M, Koblin B, Lucy D, Ortiz G, McCrossin J, Usher D, Tieu HV. A pilot study comparing sexual risk data collected via smartphone app diaries and online survey questionnaire among at-risk HIV negative men who have sex with men. Poster Presentation, IAS 2017, Paris, France, July 23-26, 2017
Richardson S, Seekaew P, Koblin B, Vazquez T, Nandi V, Tieu HV. Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City. PLoS One. 2017 Jul 19;12(7):e0181702.
Van Tieu H, Lemos M, Andrasik M, Fleming I, Nandi V, Ortiz G, Lucy D, Musuruana M, McElrath MJ, Koblin BA. Acceptability of self-collected rectal swabs for HIV exposure testing among MSM/TGW. Poster Presentation, CROI 2017, Seattle, WA, USA, February 13-16, 2017
Marte S, Williams VD, Benitez J, McCrossin J, Usher D, Hammer S, Koblin B, Tieu HV, Sobieszczyk ME. Engaging Transgender Men in Biomedical HIV Prevention Research in New York City. Poster Presentation, HIVR4P, Chicago, IL, USA, October 17-21, 2016
Nicholas KJ, Greenplate AR, Flaherty DK, Matlock BK, Juan JS, Smith RM, Irish JM, Kalams SA. Multiparameter analysis of stimulated human peripheral blood mononuclear cells: A comparison of mass and fluorescence cytometry. Cytometry A. 2016 Mar;89(3):271-80
Carpenter C, Sidney J, Kolla R, Nayak K, Tomiyama H, Tomiyama C, Padilla OA, Rozot V, Ahamed SF, Ponte C, Rolla V, Antas PR, Chandele A, Kenneth J, Laxmi S, Makgotlho E, Vanini V, Ippolito G, Kazanova AS, Panteleev AV, Hanekom W, Mayanja-Kizza H, Lewinsohn D, Saito M, McElrath MJ, Boom WH, Goletti D, Gilman R, Lyadova IV, Scriba TJ, Kallas EG, Murali-Krishna K, Sette A, Lindestam Arlehamn CS. A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents. Tuberculosis (Edinb). 2015 Dec;95(6):713-721
Williams WB, Liao HX, Moody MA, Kepler TB, Alam SM, Gao F, Wiehe K, Trama AM, Jones K, Zhang R, Song H, Marshall DJ, Whitesides JF, Sawatzki K, Hua A, Liu P, Tay MZ, Seaton KE, Shen X, Foulger A, Lloyd KE, Parks R, Pollara J, Ferrari G, Yu JS, Vandergrift N, Montefiori DC, Sobieszczyk ME, Hammer S, Karuna S, Gilbert P, Grove D, Grunenberg N, McElrath MJ, Mascola JR, Koup RA, Corey L, Nabel GJ, Morgan C, Churchyard G, Maenza J, Keefer M, Graham BS, Baden LR, Tomaras GD, Haynes BF. HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science. 2015 Aug 14;349(6249):aab1253.
Coombs A, McFarland W, Ick T, Fuqua V, Buchbinder SP, Fuchs JD. Long-chain peer referral to recruit black MSM and black transgender women for an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):e94-7.